MINDY MEYER: Open Payments
NPI 1639495716 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$573 in 38 payments from 10 companies in 2025. Trend: 2023 $714 · 2024 $801 · 2025 $573
Food & beverage: $573
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $144 |
| Amgen Inc. | 12 | $139 |
| AstraZeneca Pharmaceuticals LP | 6 | $89 |
| Xeris Pharmaceuticals, Inc. | 2 | $74 |
| Lilly USA, LLC | 3 | $47 |
| PFIZER INC. | 1 | $20 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $19 |
| Tris Pharma Inc | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
Products named: OTEZLA, AIRSUPRA, GVOKE HYPOPEN, Ozempic, Wegovy, MOUNJARO, PREVNAR 20, NEFFY.
Industry payments across TN — which companies pay providers there.
